Cargando…
复发性胸腺瘤的治疗
Thymoma is a potential malignant disease with a recurrence rate of 10% to 30% after complete resection. There is no agreement on the treatment strategy and standard for recurrent thymoma. The treatment methods include reoperation, chemotherapy, radiotherapy, targeted therapy and immunotherapy. In th...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7118328/ https://www.ncbi.nlm.nih.gov/pubmed/32102138 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.03.11 |
Ejemplares similares
-
胸腺瘤的分期进展
Publicado: (2011) -
复发/难治性非霍奇金淋巴瘤CAR-T细胞治疗后的复发机制及应对策略
Publicado: (2020) -
抗体类新药治疗复发/难治性弥漫大B细胞淋巴瘤的研究进展
Publicado: (2023) -
新免疫治疗时代下复发难治性霍奇金淋巴瘤治疗新策略
Publicado: (2019) -
BCMA-CAR-T细胞治疗多发性骨髓瘤后复发与耐药的机制及防治策略
Publicado: (2021)